# Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum

> **NCT00082563** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 14 (actual)

## Conditions studied

- Malaria, Falciparum

## Interventions

- **DRUG:** Azithromycin/Chloroquine
- **DRUG:** Chloroquine

## Key facts

- **NCT ID:** NCT00082563
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2004-11
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2011-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00082563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00082563, "Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00082563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*